Jennison Associates’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-9,616
| Closed | -$1.16M | – | 641 |
|
|
2023
Q1 | $1.16M | Hold |
9,616
| – | – | ﹤0.01% | 482 |
|
|
2022
Q4 | $1.1M | Hold |
9,616
| – | – | ﹤0.01% | 476 |
|
|
2022
Q3 | $973K | Hold |
9,616
| – | – | ﹤0.01% | 512 |
|
|
2022
Q2 | $975K | Hold |
9,616
| – | – | ﹤0.01% | 524 |
|
|
2022
Q1 | $1.12M | Hold |
9,616
| – | – | ﹤0.01% | 546 |
|
|
2021
Q4 | $1.1M | Buy |
+9,616
| New | +$1.1M | ﹤0.01% | 599 |
|
|
2020
Q4 | – | Sell |
-10,065
| Closed | -$1.13M | – | 710 |
|
|
2020
Q3 | $1.13M | Sell |
10,065
-935
| -9% | -$105K | ﹤0.01% | 541 |
|
|
2020
Q2 | $1.15M | Buy |
+11,000
| New | +$1.15M | ﹤0.01% | 517 |
|